Novartis is said to near acquisition of Avidity Biosciences for more than $70 a share (NVS:NYSE)
Seeking Alpha·2025-10-26 23:05Novartis (NYSE:NVS) is in advanced discussions to acquire Avidity Biosciences (NASDAQ:RNA), Bloomberg News reported Sunday, citing a person with knowledge of the negotiations. The Swiss pharmaceutical company is said to be preparing an offer exceeding $70 per share for the U.S.-based ...